A. Boshier

574 total citations
10 papers, 382 citations indexed

About

A. Boshier is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, A. Boshier has authored 10 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Psychiatry and Mental health. Recurrent topics in A. Boshier's work include Hormonal and reproductive studies (3 papers), Sexual function and dysfunction studies (3 papers) and Pharmacology and Obesity Treatment (2 papers). A. Boshier is often cited by papers focused on Hormonal and reproductive studies (3 papers), Sexual function and dysfunction studies (3 papers) and Pharmacology and Obesity Treatment (2 papers). A. Boshier collaborates with scholars based in United Kingdom and Canada. A. Boshier's co-authors include Saad Shakir, Lynda V. Wilton, Sanjog Kalra, Brian Chan, Gideon Koren, Adrienne Einarson, Deborah Layton, L. V. Wilton, John Eagles and Gavin Mercer and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Journal of Affective Disorders and British Journal of Urology.

In The Last Decade

A. Boshier

10 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Boshier United Kingdom 10 125 103 74 59 52 10 382
Francisco Pérez‐Riquelme Spain 12 59 0.5× 66 0.6× 77 1.0× 40 0.7× 119 2.3× 22 421
Pamela Linksted United Kingdom 6 125 1.0× 95 0.9× 27 0.4× 75 1.3× 19 0.4× 8 628
Annelienke M. van Hulst Netherlands 9 176 1.4× 38 0.4× 131 1.8× 76 1.3× 67 1.3× 17 373
Nikkie Aarts Netherlands 15 70 0.6× 81 0.8× 91 1.2× 21 0.4× 103 2.0× 24 459
M C del Río Spain 14 55 0.4× 64 0.6× 75 1.0× 84 1.4× 63 1.2× 48 605
Margaret Kotz United States 9 139 1.1× 46 0.4× 78 1.1× 42 0.7× 33 0.6× 14 345
Pascal Caillet France 13 64 0.5× 38 0.4× 63 0.9× 46 0.8× 67 1.3× 40 467
Seema M. Patidar United States 10 94 0.8× 79 0.8× 27 0.4× 52 0.9× 33 0.6× 13 416
Miri Lutski Israel 12 89 0.7× 81 0.8× 43 0.6× 52 0.9× 11 0.2× 38 453
Vasant Dhopesh United States 12 60 0.5× 67 0.7× 94 1.3× 38 0.6× 31 0.6× 26 415

Countries citing papers authored by A. Boshier

Since Specialization
Citations

This map shows the geographic impact of A. Boshier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Boshier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Boshier more than expected).

Fields of papers citing papers by A. Boshier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Boshier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Boshier. The network helps show where A. Boshier may publish in the future.

Co-authorship network of co-authors of A. Boshier

This figure shows the co-authorship network connecting the top 25 collaborators of A. Boshier. A scholar is included among the top collaborators of A. Boshier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Boshier. A. Boshier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hazell, Lorna, A. Boshier, Scott Harris, Lynda V. Wilton, & Saad Shakir. (2007). An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease. British Journal of Urology. 99(2). 387–393. 10 indexed citations
2.
Layton, Deborah, Vanessa Marshall, A. Boshier, Peter S. Friedmann, & Saad Shakir. (2006). Serious Skin Reactions and Selective COX-2 Inhibitors. Drug Safety. 29(8). 687–696. 32 indexed citations
3.
Layton, Deborah, Lynda Wilton, A. Boshier, et al.. (2006). Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine. Drug Safety. 29(10). 897–909. 26 indexed citations
4.
Maclennan, Karyn, A. Boshier, Lynda V. Wilton, & Saad Shakir. (2006). Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction. British Journal of Urology. 98(1). 125–131. 22 indexed citations
5.
Boshier, A., et al.. (2005). The negative effect of red tape on research. Pharmacoepidemiology and Drug Safety. 14(6). 373–376. 11 indexed citations
6.
Chan, Brian, Gideon Koren, Sanjog Kalra, et al.. (2005). Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study. American Journal of Obstetrics and Gynecology. 192(3). 932–936. 147 indexed citations
7.
Boshier, A., L. V. Wilton, & Saad Shakir. (2004). Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999. British Journal of Urology. 93(6). 796–801. 27 indexed citations
8.
Boshier, A., Lynda V. Wilton, & Saad Shakir. (2003). Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. European Journal of Clinical Pharmacology. 59(10). 767–773. 49 indexed citations
9.
Boshier, A., et al.. (2002). A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil. International Journal of Clinical Pharmacology and Therapeutics. 40(9). 422–423. 31 indexed citations
10.
Eagles, John, et al.. (1996). Seasonal affective disorder among psychiatric nurses in Aberdeen. Journal of Affective Disorders. 37(2-3). 129–135. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026